France Christophe Lala, general manager of western Europe for GE Healthcare offers an overview of the current dynamics impacting the French healthcare landscape – namely a shift in structure around care pathways and the hot trend of digitalization. Lala goes on to assess France’s willingness and capability to embrace this technology,…
Egypt After months of discussion, in December 2017 Egypt’s Parliament approved a new national health insurance law that aims to overcome some of the inherent problems in the current healthcare system and offer better medical services to the public. We have studied enough, the time for implementation is now! Dr…
Opinion The Foundations for Evidence-Based Policy-Making Act, recently signed into law in the USA, stands to make government data more accessible; thereby allowing researchers, statisticians and others inside and outside of government to make better, and evidenced-based, policy decisions. Carla Smith outlines the scope of the Act and its potential implications…
Malaysia Eurasia Group’s Aditya Bhattacharji discusses the relatively modest scope of Malaysia’s recently-launched ‘MYSalam’ scheme; a healthcare programme which aims to provide coverage to the country’s bottom 40 percent of earners. For the time being, the outlook for the private sector, including for pharmaceutical firms, is good Another populist government,…
China Research has established that proper nutrition during hospitalization helps to reduce the number of infections, the duration of treatment needed for recovery, and reduce the readmission rateCecily Gu discusses her move from traditional pharma to a broader healthcare company, the significance of the Greater China region to the global Nestlé…
AI GSK’s Richard Saynor outlines the ways in which an increased embrace of technologies which utilise artificial intelligence can help improve health literacy and therefore patient outcomes. In healthcare, AI has the potential to improve drug discovery, development and manufacturing, and enhance interactions with customers, doctors and patients As a…
WHO Brendan Shaw outlines how a new approach to the WHO’s Essential Medicines List is needed to ensure both the patients of today and of the future can access the medicines they need. For pharmaceutical companies, listing on the EML can be a double-edged sword. More than 40 years after its…
Egypt Rates of tuberculosis (TB) have dropped dramatically in Egypt over the last 30 years, but there is still work to be done, with the country’s Ministry of Health recently announcing a new campaign to combat the prevalence of the disease Thanks to the rollout of a national anti-TB programme,…
Korea Steve Hong, CEO, and Tony Lim, vice president & COO of Lemon Healthcare, lift the lid on the new streamlined hospital data services they are offering, and the benefits to speed and cost effectiveness that they will bring to healthcare providers and patients. Lim also reveals his strategy to expand…
Opinion Kamala Maddali, vice president for Biopharma Collaborations & Companion Diagnostics at Cancer Genetics, discusses what impact next generation sequencing (NGS) stands to have on cancers that affect women. NGS technology allows for the rapid and accurate sequencing of many genes at once 2018 saw an estimated 18 million cancer…
Korea YongBum Choi, general manager of Ferring Korea, explains how he plans to foster the Ferring values in the local affiliate. Mr Choi also breaks down the stigmas associated with assisted reproductive technologies and lays down Ferring’s ambitious growth strategy through breakthrough products launches every two years in Uro-Oncology & Gastroenterology.…
Korea Pil Soo Oh has been the managing director of Lundbeck Korea since the establishment of the affiliate in 2002. Mr Oh offers his insights into Lundbeck’s footprint in Korea, their plans to adapt locally to Lundbeck’s new global strategy, and the issues of stigma towards mental illness in Korean society.…
See our Cookie Privacy Policy Here